ruthenium has been researched along with Animal Mammary Carcinoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergamo, A; Dyson, PJ; Riedel, T; Sava, G | 1 |
| Cocchietto, M; Sava, G; Sorc, A; Zorzet, S | 1 |
| Alessio, E; Bergamo, A; Casarsa, C; Cocchietto, M; Haasnoot, JG; Sava, G; Velders, AH; Zangrando, E; Zorzet, S | 1 |
| Casarsa, C; Mischis, MT; Sava, G | 1 |
4 other study(ies) available for ruthenium and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Preclinical combination therapy of the investigational drug NAMI-A(+) with doxorubicin for mammary cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Dimethyl Sulfoxide; Doxorubicin; Humans; Kidney; Liver; Lung; Lung Neoplasms; Mammary Neoplasms, Animal; MCF-7 Cells; Mice, Inbred CBA; Organometallic Compounds; Ruthenium; Ruthenium Compounds | 2015 |
Primary tumor, lung and kidney retention and antimetastasis effect of NAMI-A following different routes of administration.
Topics: Administration, Inhalation; Administration, Oral; Aerosols; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Dimethyl Sulfoxide; Disease Models, Animal; Female; Injections, Intraperitoneal; Kidney; Liver; Lung; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Organometallic Compounds; Ruthenium; Ruthenium Compounds; Species Specificity | 2003 |
Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]p
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Hydrolysis; Kidney; Liver; Lung Neoplasms; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Animal; Matrix Metalloproteinase 9; Mice; Molecular Structure; Neoplasm Invasiveness; Neoplasm Metastasis; Organometallic Compounds; Ruthenium; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Tissue Distribution | 2004 |
TGFbeta1 regulation and collagen-release-independent connective tissue re-modelling by the ruthenium complex NAMI-A in solid tumours.
Topics: Animals; Cell Line, Tumor; Coculture Techniques; Collagen; Connective Tissue; Dimethyl Sulfoxide; Female; Gene Expression Regulation, Neoplastic; Mammary Neoplasms, Animal; Mice; Mice, Inbred CBA; Molecular Structure; NIH 3T3 Cells; Organometallic Compounds; Ruthenium; Ruthenium Compounds; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |